PNC Financial Services Group
RLAY icon

PNC Financial Services Group’s Relay Therapeutics RLAY Stock Holding History

PNC Financial Services Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$440K Buy
23,491
+18,998
+423% +$276K ﹤0.01% 1882
2026
Q1 		$44.7K Sell
4,493
-113
-2% -$1.01K ﹤0.01% 3279
2025
Q4 		$39K Sell
4,606
-48
-1% -$343 ﹤0.01% 3349
2025
Q3 		$24.3K Buy
4,654
+1,370
+42% +$5.22K ﹤0.01% 3558
2025
Q2 		$11.4K Buy
3,284
+1,850
+129% +$5.5K ﹤0.01% 3810
2025
Q1 		$3.76K Buy
1,434
+1,340
+1,426% +$5.25K ﹤0.01% 4154
2024
Q4 		$387 Buy
94
+15
+19% +$82 ﹤0.01% 4564
2024
Q3 		$559 Hold
79
– – ﹤0.01% 4550
2024
Q2 		$515 Sell
79
-167
-68% -$1.14K ﹤0.01% 4525
2024
Q1 		$2.04K Buy
246
+200
+435% +$1.95K ﹤0.01% 4189
2023
Q4 		$506 Buy
+46
New +$388 ﹤0.01% 4414
2023
Q1 		– Sell
-6
Closed -$90 – 4798
2022
Q4 		$90 Hold
6
– – ﹤0.01% 4701
2022
Q3 		$0 Buy
+6
New +$132 ﹤0.01% 4585

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PNC Financial Services Group's RLAY Position: Q2 2026 in Review

PNC Financial Services Group increased its Relay Therapeutics (RLAY) stake by 423% in Q2 2026, buying an estimated $276K and bringing the position to 23,491 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1882.

PNC Financial Services Group first reported a position in RLAY in Q3 2022 and has held it in 13 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • PNC Financial Services Group held 23,491 shares of Relay Therapeutics worth $440K as of Q2 2026.
  • PNC Financial Services Group bought 18,998 Relay Therapeutics shares in Q2 2026, an estimated $276K.
  • Relay Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1882 holding.
  • PNC Financial Services Group first reported a position in Relay Therapeutics in Q3 2022 and has held it in 13 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.